Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 931

1.

A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer.

Knipper S, Pecoraro A, Palumbo C, Rosiello G, Luzzago S, Tian Z, Briganti A, Saad F, Tilki D, Graefen M, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Jul 19. pii: S1558-7673(19)30224-1. doi: 10.1016/j.clgc.2019.07.008. [Epub ahead of print]

PMID:
31416752
2.

The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.

Mazzone E, Preisser F, Nazzani S, Tian Z, Bandini M, Gandaglia G, Fossati N, Montorsi F, Graefen M, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Eur Urol Oncol. 2018 Nov 22. pii: S2588-9311(18)30191-3. doi: 10.1016/j.euo.2018.10.010. [Epub ahead of print]

PMID:
31411992
3.

Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups.

Preisser F, Bandini M, Nazzani S, Mazzone E, Marchioni M, Tian Z, Chun FKH, Saad F, Briganti A, Haese A, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol Oncol. 2019 Mar 28. pii: S2588-9311(19)30035-5. doi: 10.1016/j.euo.2019.03.003. [Epub ahead of print]

PMID:
31411975
4.

Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes.

Moschini M, Zamboni S, Soria F, Mathieu R, Xylinas E, Tan WS, Kelly JD, Simone G, Meraney A, Krishna S, Konety B, Mattei A, Baumeister P, Mordasini L, Montorsi F, Briganti A, Gallina A, Stabile A, Sanchez-Salas R, Cathelineau X, Rink M, Necchi A, Karakiewicz PI, Rouprêt M, Koupparis A, Kassouf W, Scherr DS, Ploussard G, Boorjian SA, Lotan Y, Sooriakumaran P, Shariat SF.

J Clin Med. 2019 Aug 9;8(8). pii: E1192. doi: 10.3390/jcm8081192.

5.

Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors.

Palumbo C, Mistretta FA, Mazzone E, Knipper S, Tian Z, Perrotte P, Antonelli A, Montorsi F, Shariat SF, Saad F, Simeone C, Briganti A, Lattouf JB, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Jun 13. pii: S1558-7673(19)30196-X. doi: 10.1016/j.clgc.2019.06.003. [Epub ahead of print]

PMID:
31378580
6.

Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate Cancer.

Preisser F, Nazzani S, Mazzone E, Marchioni M, Bandini M, Tian Z, Haese A, Saad F, Zorn K, Montorsi F, Shariat SF, Graefen M, Tilki D, Karakiewicz PI.

Clin Genitourin Cancer. 2019 May 27. pii: S1558-7673(19)30160-0. doi: 10.1016/j.clgc.2019.05.022. [Epub ahead of print]

PMID:
31375352
7.

Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis.

Palumbo C, Pecoraro A, Knipper S, Rosiello G, Tian Z, Shariat SF, Simeone C, Briganti A, Saad F, Berruti A, Antonelli A, Karakiewicz PI.

Anticancer Res. 2019 Aug;39(8):4357-4361. doi: 10.21873/anticanres.13604.

PMID:
31366530
8.

In Non-Metastatic pT1b Kidney Cancer Patients Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy.

Pecoraro A, Palumbo C, Knipper S, Mistretta FA, Tian Z, Shariat SF, Saad F, Briganti A, Fiori C, Porpiglia F, Karakiewicz PI.

J Urol. 2019 Jul 26:101097JU0000000000000460. doi: 10.1097/JU.0000000000000460. [Epub ahead of print]

PMID:
31347950
9.

Impact of obesity on perioperative outcomes at robotic-assisted and open radical prostatectomy: results from the National Inpatient Sample.

Knipper S, Mazzone E, Mistretta FA, Palumbo C, Tian Z, Briganti A, Saad F, Tilki D, Graefen M, Karakiewicz PI.

Urology. 2019 Jul 20. pii: S0090-4295(19)30646-6. doi: 10.1016/j.urology.2019.05.053. [Epub ahead of print]

PMID:
31336110
10.

Conditional survival of patients with stage I-III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality.

Mistretta FA, Palumbo C, Knipper S, Mazzone E, Pecoraro A, Tian Z, Musi G, Perrotte P, Montanari E, Shariat SF, Saad F, Briganti A, de Cobelli O, Karakiewicz PI.

World J Urol. 2019 Jul 11. doi: 10.1007/s00345-019-02869-6. [Epub ahead of print]

PMID:
31297629
11.

How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder.

Palumbo C, Mistretta FA, Knipper S, Pecoraro A, Tian Z, Shariat SF, Saad F, Simeone C, Briganti A, Antonelli A, Karakiewicz PI.

Urol Oncol. 2019 Jul 8. pii: S1078-1439(19)30220-0. doi: 10.1016/j.urolonc.2019.05.020. [Epub ahead of print]

PMID:
31296422
12.

Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy: A systematic literature review and meta-analysis.

Kardoust Parizi M, Abufaraj M, Fajkovic H, Kimura S, Iwata T, D'Andrea D, Karakiewicz PI, Shariat SF.

Urol Oncol. 2019 Jul 8. pii: S1078-1439(19)30236-4. doi: 10.1016/j.urolonc.2019.06.007. [Epub ahead of print] Review.

PMID:
31296421
13.

Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates.

Mistretta FA, Mazzone E, Palumbo C, Knipper S, Tian Z, Nazzani S, Tilki D, Musi G, Perrotte P, Montanari E, Shariat SF, Saad F, Briganti A, de Cobelli O, Karakiewicz PI.

Urol Oncol. 2019 Sep;37(9):578.e11-578.e19. doi: 10.1016/j.urolonc.2019.05.024. Epub 2019 Jul 8.

PMID:
31296420
14.

Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network.

Grosset AA, Ouellet V, Caron C, Fragoso G, Barrès V, Delvoye N, Latour M, Aprikian A, Bergeron A, Chevalier S, Fazli L, Fleshner N, Gleave M, Karakiewicz P, Lacombe L, Lattouf JB, van der Kwast T, Trudel D, Mes-Masson AM, Saad F; Canadian Prostate Cancer Biomarker Network.

PLoS Med. 2019 Jul 2;16(7):e1002847. doi: 10.1371/journal.pmed.1002847. eCollection 2019 Jul.

15.

Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients.

Palumbo C, Knipper S, Dzyuba-Negrean C, Pecoraro A, Rosiello G, Tian Z, Shariat SF, Simeone C, Briganti A, Saad F, Berruti A, Antonelli A, Karakiewicz PI.

J Geriatr Oncol. 2019 Jun 27. pii: S1879-4068(19)30196-1. doi: 10.1016/j.jgo.2019.06.005. [Epub ahead of print]

PMID:
31257163
16.

Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer.

Iwata T, Kimura S, Abufaraj M, Janisch F, Parizi MK, Haitel A, Rink M, Rouprêt M, Fajkovic H, Seebacher V, Nyirady P, Karakiewicz PI, Enikeev D, Rapoport LM, Nasu Y, Shariat SF.

Urol Oncol. 2019 Jun 26. pii: S1078-1439(19)30219-4. doi: 10.1016/j.urolonc.2019.05.019. [Epub ahead of print]

PMID:
31255543
17.

The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: A systematic review.

Iwata T, Kimura S, Abufaraj M, Janisch F, Karakiewicz PI, Seebacher V, Rouprêt M, Nasu Y, Shariat SF.

Urol Oncol. 2019 Jun 26. pii: S1078-1439(19)30221-2. doi: 10.1016/j.urolonc.2019.05.021. [Epub ahead of print] Review.

PMID:
31255542
18.
19.

Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma.

Mason RJ, Wood L, Kapoor A, Basappa N, Bjarnason G, Boorjian SA, Breau RH, Cagiannos I, Jewett MAS, Karakiewicz PI, Kassouf W, Kollmannsberger C, Lalani AA, Lattouf JB, Lavallée LT, Pautler S, Power N, Richard P, So A, Tanguay S, Rendon RA.

Can Urol Assoc J. 2019 Jun;13(6):166-174. doi: 10.5489/cuaj.5786. No abstract available.

20.

Editorial Comment.

Karakiewicz PI.

J Urol. 2019 Sep;202(3):531. doi: 10.1097/01.JU.0000569232.25218.7c. Epub 2019 Aug 8. No abstract available.

PMID:
31192750

Supplemental Content

Loading ...
Support Center